VP of Research and Special Initiatives, Google
Partner, Emerging Companies and Life Sciences, Cooley LLP
Professor of Leadership, Emeritus at the Harvard Business School
Managing Partner, Triathalon Medical Ventures Fund II
Co-Founder, Fate Therapeutics
Chairman and CEO, Accelerator
Professor of Biomedical Engineering, Boston University
Professor, MIT Sloan School of Management
|
|
A jury in U.S. District Court in San Francisco yesterday found that Boston Scientific (NYSE:BSX) infringes a patent for balloon catheter technology held by Johnson & Johnson subsidiary Cordis Corp. Boston Scientific said it believes the finding is in error and that it will seek to have it overturned.
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
